{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:14:04Z","timestamp":1761218044222,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71173245","81473065"],"award-info":[{"award-number":["71173245","81473065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Medical Board (US)","award":["12-111"],"award-info":[{"award-number":["12-111"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13011-017-0140-3","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T07:11:55Z","timestamp":1515568315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Strategies to control HIV and HCV in methadone maintenance treatment in Guangdong Province, China: a system dynamic modeling study"],"prefix":"10.1186","volume":"13","author":[{"given":"Xia","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghua","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"issue":"12","key":"140_CR1","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192\u2013207.","journal-title":"Lancet Glob Health"},{"key":"140_CR2","unstructured":"United Nation Office on Drugs and Crime (UNODC). World Drug Report. New York: United Nation; 2016."},{"issue":"5","key":"140_CR3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugpo.2007.04.004","volume":"18","author":"C Aceijas","year":"2007","unstructured":"Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007;18(5):352\u20138.","journal-title":"Int J Drug Policy"},{"issue":"9791","key":"140_CR4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","volume":"378","author":"PK Nelson","year":"2011","unstructured":"Nelson PK, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378(9791):571\u201383.","journal-title":"Lancet"},{"key":"140_CR5","unstructured":"Office, N.N.C., 2017 National Narcotics Control Report. Beijing: National Narcotics Control Office; 2017."},{"issue":"3","key":"140_CR6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11481-016-9665-x","volume":"11","author":"Y-I Hser","year":"2016","unstructured":"Hser Y-I, et al. Drug abuse, HIV, and HCV in Asian countries. J NeuroImmune Pharmacol. 2016;11(3):383\u201393.","journal-title":"J NeuroImmune Pharmacol"},{"key":"140_CR7","volume-title":"Progress report on the prevention and control of HIV\/AIDS","author":"China, H.a.F.P.C.o.t.P.s.R.o","year":"2015","unstructured":"China, H.a.F.P.C.o.t.P.s.R.o., Progress report on the prevention and control of HIV\/AIDS. 2015."},{"issue":"7","key":"140_CR8","doi-asserted-by":"crossref","first-page":"e68906","DOI":"10.1371\/journal.pone.0068906","volume":"8","author":"L Zhang","year":"2013","unstructured":"Zhang L, et al. Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysis. PLoS One. 2013;8(7):e68906.","journal-title":"PLoS One"},{"issue":"1","key":"140_CR9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugpo.2014.09.004","volume":"26","author":"N Zaller","year":"2015","unstructured":"Zaller N, et al. Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care. Int J Drug Policy. 2015;26(1):37\u201342.","journal-title":"Int J Drug Policy"},{"issue":"8","key":"140_CR10","doi-asserted-by":"crossref","first-page":"e008162","DOI":"10.1136\/bmjopen-2015-008162","volume":"5","author":"X Zou","year":"2015","unstructured":"Zou X, Ling L, Zhang L. Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study. BMJ Open. 2015;5(8):e008162.","journal-title":"BMJ Open"},{"key":"140_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.drugalcdep.2015.10.001","volume":"157","author":"C Marienfeld","year":"2015","unstructured":"Marienfeld C, et al. Evaluation of an implementation of methadone maintenance treatment in China. Drug Alcohol Depend. 2015;157:60\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"140_CR12","first-page":"305","volume":"38","author":"P Lin","year":"2004","unstructured":"Lin P, et al. Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China. Zhonghua Yu Fang Yi Xue Za Zhi. 2004;38(5):305\u20138.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"140_CR13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/1471-2458-11-693","volume":"11","author":"SY Shen","year":"2011","unstructured":"Shen SY, et al. Peer-based behavioral health program for drug users in China: a pilot study. BMC Public Health. 2011;11:693.","journal-title":"BMC Public Health"},{"issue":"4","key":"140_CR14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/OLQ.0b013e31827fd4d4","volume":"40","author":"Y Ruan","year":"2013","unstructured":"Ruan Y, et al. Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China. Sex Transm Dis. 2013;40(4):323\u20138.","journal-title":"Sex Transm Dis"},{"issue":"9719","key":"140_CR15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","volume":"375","author":"BM Mathers","year":"2010","unstructured":"Mathers BM, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):1014\u201328.","journal-title":"Lancet"},{"issue":"7","key":"140_CR16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/sti.2010.045500","volume":"87","author":"LF Johnson","year":"2011","unstructured":"Johnson LF, White PJ. A review of mathematical models of HIV\/AIDS interventions and their implications for policy. Sex Transm Infect. 2011;87(7):629\u201334.","journal-title":"Sex Transm Infect"},{"issue":"6 Pt B","key":"140_CR17","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3851\/IMP2428","volume":"17","author":"A Chatterjee","year":"2012","unstructured":"Chatterjee A, Guedj J, Perelson AS. Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents? Antivir Ther. 2012;17(6 Pt B):1171\u201382.","journal-title":"Antivir Ther"},{"issue":"e1","key":"140_CR18","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1136\/amiajnl-2012-001289","volume":"20","author":"JA Merrill","year":"2013","unstructured":"Merrill JA, et al. A system dynamics evaluation model: implementation of health information exchange for public health reporting. J Am Med Inform Assoc. 2013;20(e1):e131\u20138.","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"140_CR19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2105\/AJPH.2005.062059","volume":"96","author":"JB Homer","year":"2006","unstructured":"Homer JB, Hirsch GB. System dynamics modeling for public health: background and opportunities. Am J Public Health. 2006;96(3):452\u20138.","journal-title":"Am J Public Health"},{"issue":"2","key":"140_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/sdr.211","volume":"17","author":"BC Dangerfield","year":"2001","unstructured":"Dangerfield BC, Fang Y, Roberts CA. Model-based scenarios for the epidemiology of HIV\/AIDS: the consequences of highly active antiretroviral therapy. Syst Dyn Rev. 2001;17(2):119\u201350.","journal-title":"Syst Dyn Rev"},{"key":"140_CR21","first-page":"68","volume-title":"The international conference-system dynamics society","author":"W Qu","year":"1998","unstructured":"Qu W, Symalla D, Barney GO. The HIV\/AIDS sector in THRESHOLD 21 Malawi. In: The international conference-system dynamics society; 1998. p. 68."},{"issue":"1 Suppl","key":"140_CR22","doi-asserted-by":"crossref","first-page":"111s","DOI":"10.1177\/1090198113490723","volume":"40","author":"MR Weeks","year":"2013","unstructured":"Weeks MR, et al. Multilevel dynamic systems affecting introduction of HIV\/STI prevention innovations among Chinese women in sex work establishments. Health Educ Behav. 2013;40(1 Suppl):111s\u201322s.","journal-title":"Health Educ Behav"},{"issue":"1","key":"140_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1524839909332137","volume":"12","author":"RL Miller","year":"2011","unstructured":"Miller RL, et al. A dynamic model of client recruitment and retention in community-based HIV prevention programs. Health Promot Pract. 2011;12(1):135\u201346.","journal-title":"Health Promot Pract"},{"issue":"10","key":"140_CR24","doi-asserted-by":"crossref","first-page":"e0139942","DOI":"10.1371\/journal.pone.0139942","volume":"10","author":"L Zhang","year":"2015","unstructured":"Zhang L, et al. Investigation of repeat client drop-out and re-enrolment cycles in fourteen methadone maintenance treatment clinics in Guangdong, China. PLoS One. 2015;10(10):e0139942.","journal-title":"PLoS One"},{"issue":"6","key":"140_CR25","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.drugpo.2013.03.010","volume":"24","author":"J Meng","year":"2013","unstructured":"Meng J, Burris S. The role of the Chinese police in methadone maintenance therapy: a literature review. Int J Drug Policy. 2013;24(6):e25\u201334.","journal-title":"Int J Drug Policy"},{"key":"140_CR26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/add.12782","volume":"110","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, et al. Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme. Addiction. 2015;110:40\u201350.","journal-title":"Addiction"},{"issue":"Supplement C","key":"140_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drugalcdep.2016.05.005","volume":"164","author":"L Deng","year":"2016","unstructured":"Deng L, et al. How clients\u2019 during-treatment motivations relate to their perceptions and impressions of methadone maintenance treatment: a multilevel analysis of a cross-sectional survey in Guangdong Province, China. Drug Alcohol Depend. 2016;164(Supplement C):151\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"140_CR28","doi-asserted-by":"crossref","unstructured":"Liu Y, et al. Trends and factors in human immunodeficiency virus and\/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong province, China: 2006-2013: a consecutive, cross-sectional study. BMJ Open. 2017;7(7):e015524.","DOI":"10.1136\/bmjopen-2016-015524"},{"issue":"9","key":"140_CR29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1360-0443.2007.01913.x","volume":"102","author":"JL Sindelar","year":"2007","unstructured":"Sindelar JL, Olmstead TA, Peirce JM. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction. 2007;102(9):1463\u201371.","journal-title":"Addiction"},{"issue":"10","key":"140_CR30","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1360-0443.2011.03490.x","volume":"106","author":"YI Hser","year":"2011","unstructured":"Hser YI, et al. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction. 2011;106(10):1801\u20139.","journal-title":"Addiction"},{"issue":"1","key":"140_CR31","first-page":"11","volume":"24","author":"H Jiang","year":"2012","unstructured":"Jiang H, et al. Efficacy of contingency management in improving retention and compliance to methadone maintenance treatment: a random controlled study. Shanghai Arch Psychiatry. 2012;24(1):11\u20139.","journal-title":"Shanghai Arch Psychiatry"},{"issue":"1","key":"140_CR32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2013.06.005","volume":"133","author":"M Kidorf","year":"2013","unstructured":"Kidorf M, et al. Reinforcing integrated psychiatric service attendance in an opioid-agonist program: a randomized and controlled trial. Drug Alcohol Depend. 2013;133(1):30\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"140_CR33","volume-title":"School of public health","author":"W Chen","year":"2013","unstructured":"Chen W. Effectiveness and health economics evaluation on psychosocial and behavioral intervention among community-based methadone maintenance treatment. In: School of public health. Guangzhou: Sun Yat-sen University; 2013."},{"issue":"3","key":"140_CR34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.drugalcdep.2005.11.023","volume":"83","author":"NM Petry","year":"2006","unstructured":"Petry NM, et al. Prize-based contingency management does not increase gambling. Drug Alcohol Depend. 2006;83(3):269\u201373.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"140_CR35","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1360-0443.2012.03859.x","volume":"107","author":"J Gu","year":"2012","unstructured":"Gu J, et al. Misconceptions predict dropout and poor adherence prospectively among newly admitted first-time methadone maintenance treatment clients in Guangzhou, China. Addiction. 2012;107(9):1641\u20139.","journal-title":"Addiction"},{"issue":"7","key":"140_CR36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/QAD.0000000000000135","volume":"28","author":"N Blaser","year":"2014","unstructured":"Blaser N, et al. Impact of viral load and the duration of primary infection on HIV transmission: systematic review and meta-analysis. AIDS. 2014;28(7):1021\u20139.","journal-title":"AIDS"},{"key":"140_CR37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2015.06.032","volume":"154","author":"H Valerio","year":"2015","unstructured":"Valerio H, et al. Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: implications for reinfection. Drug Alcohol Depend. 2015;154:125\u201331.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"140_CR38","first-page":"90","volume":"8","author":"Z Alam-Mehrjerdi","year":"2016","unstructured":"Alam-Mehrjerdi Z, et al. Willingness to receive treatment for hepatitis C among injecting drug users on methadone program: implications for education and treatment. Addict Health. 2016;8(2):90\u20137.","journal-title":"Addict Health"},{"issue":"2","key":"140_CR39","doi-asserted-by":"crossref","first-page":"ofw065","DOI":"10.1093\/ofid\/ofw065","volume":"3","author":"CE Chu","year":"2016","unstructured":"Chu CE, et al. Hepatitis C virus treatment access among human immunodeficiency virus and hepatitis C virus (HCV)-Coinfected people who inject drugs in Guangzhou, China: implications for HCV treatment expansion. Open Forum Infect Dis. 2016;3(2):ofw065.","journal-title":"Open Forum Infect Dis"},{"key":"140_CR40","unstructured":"Organization, C.D.T. Registration and Information Publicity Platform of China Drug Clinical Trials. 2016 [cited 2016 December 13]; Available from: http:\/\/www.chinadrugtrials.org.cn\/eap\/clinicaltrials.searchlist?a=a&keywords=\u4e19\u809d. Accessed 13 Dec 2016."},{"key":"140_CR41","unstructured":"Jamieson, Beals, and Lalonde, Best Practices: Methadone Maintenance Treatment. Ottawa, Ontario: Office of Canada's Drug Strategy Health Canada; 2002."}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-017-0140-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T07:12:40Z","timestamp":1515568360000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-017-0140-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1186\/s13011-017-0140-3","relation":{},"ISSN":["1747-597X"],"issn-type":[{"type":"electronic","value":"1747-597X"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"article-number":"1"}}